Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients: genetic analysis of the CYP2C9 locus
- 1 February 2000
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Pharmacogenetics
- Vol. 10 (1) , 85-89
- https://doi.org/10.1097/00008571-200002000-00011
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Genetic Polymorphism of Cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese PopulationTherapeutic Drug Monitoring, 1998
- Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes*Clinical Pharmacology & Therapeutics, 1998
- Genetic polymorphism of the CYP2C subfamily and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy*Clinical Pharmacology & Therapeutics, 1997
- Allelic and functional variability of cytochrome P4502C9Pharmacogenetics, 1997
- Genetic analysis of the human cytochrome P450 CYP2C9 locusPharmacogenetics, 1996
- The role of the CFP2C9-Leu 359 allelic variant in the tolbutamide polymorphismPharmacogenetics, 1996
- Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapyPharmacogenetics, 1995
- Site-directed mutation studies of human liver cytochrome P-450 isoenzymes in the CYP2C subfamilyBiochemical Journal, 1993
- Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamilyBiochemistry, 1991